Similarly, in pancreatic cancer, elevated collagen type I levels promote gemcitabine resistance by upregulating HMGA2, a protein involved in chromatin remodeling, cell proliferation, and DNA repair [41,42]. Here, HMGA2 is linked to pancreatic neoplasm.